34 related articles for article (PubMed ID: 3556417)
1. Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
Grzywa M
Exp Clin Endocrinol; 1986 Dec; 88(3):325-33. PubMed ID: 3556417
[TBL] [Abstract][Full Text] [Related]
2. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
Vizner B; Reiner Z; Sekso M
Exp Clin Endocrinol; 1983 Jan; 81(1):41-8. PubMed ID: 6343098
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone response to L-dopa in the thinned obese.
Laurian L; Oberman Z; Hoerer E; Wiznitzer T; Harell A
Isr J Med Sci; 1982 May; 18(5):625-9. PubMed ID: 7096047
[TBL] [Abstract][Full Text] [Related]
4. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
[TBL] [Abstract][Full Text] [Related]
5. Effect of ethanol on serum concentrations of somatomedin C and the growth hormone (GH) secretion stimulated by the releasing hormone (GHRH).
Välimäki M; Pelkonen R; Karonen SL; Ylikahri R
Alcohol Alcohol Suppl; 1987; 1():557-9. PubMed ID: 3122774
[TBL] [Abstract][Full Text] [Related]
6. [The L-DOPA-propranolol test for the evaluation of reserves in secretory growth hormone].
Frisch H; Schober E; Stransky E
Wien Klin Wochenschr; 1983 Aug; 95(16):566-8. PubMed ID: 6649642
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of levodopa-propranolol as a test of growth hormone reserve in children.
Collu R; Brun G; Milsant F; Leboeuf G; Letarte J; Ducharme JR
Pediatrics; 1978 Feb; 61(2):242-4. PubMed ID: 634678
[TBL] [Abstract][Full Text] [Related]
8. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone secretion in empty sella syndrome.
Brismar K
J Endocrinol Invest; 1982; 5(6):417-22. PubMed ID: 6763056
[TBL] [Abstract][Full Text] [Related]
10. Adrenergic modulation of growth hormone secretion in acromegaly: alpha- and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppresion.
Cryer PE; Daughaday WH
J Clin Endocrinol Metab; 1977 May; 44(5):977-9. PubMed ID: 870520
[TBL] [Abstract][Full Text] [Related]
11. Rapid changes in somatomedin activity during insulin-induced hypoglycemia: possible release of an inhibitory factor.
Hill DJ; Potter JM; Cullen DR; Milner RD
J Clin Endocrinol Metab; 1981 Aug; 53(2):439-42. PubMed ID: 7019232
[TBL] [Abstract][Full Text] [Related]
12. Serum somatomedin activity and growth hormone secretion by cultured pituitary cells from genetically obese Zucker rats.
Grzywa M
Endokrynol Pol; 1984; 35(2):105-11. PubMed ID: 6745203
[No Abstract] [Full Text] [Related]
13. Growth hormone response to propranolol and L--dopa in obese subjects.
Barbarine A; De Marinis L; Troncone L
Metabolism; 1978 Mar; 27(3):275-8. PubMed ID: 628352
[TBL] [Abstract][Full Text] [Related]
14. [Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
Cabezas-Cerrato J; Mur AL; Aranguren LV; Vila T; Fernández-Cruz A
Rev Clin Esp; 1975 Jun; 137(6):497-502. PubMed ID: 1162133
[No Abstract] [Full Text] [Related]
15. [Growth hormone and somatomedin activity in children with anorexia nervosa, relation to weight changes (proceedings) (author's transl)].
Rappaport R; Prevot C; Czernichow P
Ann Endocrinol (Paris); 1978; 39(3):259-60. PubMed ID: 718129
[No Abstract] [Full Text] [Related]
16. Plasma somatomedin activity in obese-hyperglycemic mice.
Spencer GS; Enser MB
Horm Metab Res; 1979 Oct; 11(9):528-30. PubMed ID: 500007
[No Abstract] [Full Text] [Related]
17. [Secretion of growth hormone in obese subjects on starvation diet].
Zahorska-Markiewicz B; Kokot F; Kuska J
Pol Arch Med Wewn; 1974 Dec; 52(6):581-8. PubMed ID: 4438129
[No Abstract] [Full Text] [Related]
18. [Use of the standard slope method for determining serum somatomedin activity (SSA)].
Oktaba W; Grzywa M
Endokrynol Pol; 1984; 35(1):51-5. PubMed ID: 6734531
[No Abstract] [Full Text] [Related]
19. [Growth hormone release during dynamic tests performed on obese patients].
Ponikowska I; Graczykowska-Koczorowska A; Zietek J; Kosowicz J; Porawska J
Endokrynol Pol; 1981; 32(6):445-52. PubMed ID: 7347275
[No Abstract] [Full Text] [Related]
20. The levodopa-propranolol test for growth hormone screening.
Itami RM; Geffner ME; Kaplan SA; Lippe BM
J Pediatr; 1982 May; 100(5):838. PubMed ID: 7069557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
